In a phase I trial, patients receiving 260 mg/m2 of albumin-bound paclitaxel experienced grade 2 and 3 encephalopathy with low-intensity pulsed ultrasound and concomitant administration of intravenous microbubbles (LIPU-MB) [25]. The gene discussed is ALB; the disease is Encephalopathy.